Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infections
Lida Jafari Saraf, Samuel Eric Wilson21Veterans Administration Medical Center, Long Beach, CA, USA; 2Department of Surgery, University of California, Irvine, CA, USAAbstract: Telavancin, a novel lipoglycopeptide with rapid concentration-dependent bactericidal effects, is a semisynthetic derivative o...
Main Authors: | Lida Jafari Saraf, Samuel Eric Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-03-01
|
Series: | Infection and Drug Resistance |
Online Access: | http://www.dovepress.com/telavancin-a-new-lipoglycopeptide-antimicrobial-in-complicated-skin-an-a6615 |
Similar Items
-
Role of telavancin in treatment of skin and skin structure infections
by: Joseph Bonkowski, et al.
Published: (2010-10-01) -
A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)
by: Lala M Dunbar, et al.
Published: (2008-03-01) -
New Frontier on Antimicrobial Therapy: Long-Acting Lipoglycopeptides
by: Valentina Siciliano, et al.
Published: (2024-02-01) -
Clinical Experience with Telavancin: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
by: Adam M. Bressler, et al.
Published: (2019-11-01) -
Clinical Experience with Telavancin for the Treatment of Patients with Bacteremia and Endocarditis: Real-World Results from the Telavancin Observational Use Registry (TOUR™)
by: Joseph Reilly, et al.
Published: (2020-05-01)